Evidence map›Paper›PMID 32423091›Full record

ReviewPolymers2020

History of Cyclodextrin Nanosponges.

Ilona Krabicová, Silvia Lucia Appleton, Maria Tannous, Gjylije Hoti, Fabrizio Caldera, Alberto Rubin Pedrazzo, Claudio Cecone, Roberta Cavalli, Francesco Trotta

Open access · goldAbstract readReview
In one paragraph

Review in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 146 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cyclodextrin-based therapeutics delivery systems: A review of current clinical trials.Current research in pharmacology and drug discovery · 2025
    Review
  15. Multifunctional Drug Delivery System: Nanosponges.Recent patents on nanotechnology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ilona KrabicováDepartment of Nanochemistry, Advanced Technologies and Innovation, Technical Institute for Nanomaterials, University of Liberec, Studentská 1402/2, 461 17 Liberec, Czech Republic.ORCID 0000-0002-6840-260X
Silvia Lucia AppletonDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
Maria TannousDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0001-9281-0710
Gjylije HotiDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
Fabrizio CalderaDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.ORCID 0000-0003-2581-0555
Alberto Rubin PedrazzoDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
Claudio CeconeDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
Roberta CavalliDepartment of Drug Science and Technology, University of Torino, via P. Giuria 9, 10125 Torino, Italy.
Francesco TrottaDepartment of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.
University of Turin · ITTechnical University of Liberec · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, research in the field of nanotechnology and nanomedicine has become increasingly predominant, focusing on the manipulation and development of materials on a nanometer scale. Polysaccharides have often been used as they are safe, non-toxic, hydrophilic, biodegradable and are low cost. Among them, starch derivatives and, in particular, cyclodextrin-based nanosponges (CD NSs) have recently emerged due to the outstanding properties attributable to their peculiar structure. In fact, alongside the common polysaccharide features, such as the presence of tunable functional groups and their ability to interact with biological tissues, thus giving rise to bioadhesion, which is particularly useful in drug delivery, what makes CD NSs unique is their three-dimensional network made up of crosslinked cyclodextrin units. The name "nanosponge" appeared for the first time in the 1990s due to their nanoporous, sponge-like structure and responded to the need to overcome the limitations of native cyclodextrins (CDs), particularly their water solubility and inability to encapsulate charged and large molecules efficiently. Since CD NSs were introduced, efforts have been made over the years to understand their mechanism of action and their capability to host molecules with low or high molecular weight, charged, hydrophobic or hydrophilic by changing the type of cyclodextrin, crosslinker and degree of crosslinking used. They enabled great advances to be made in various fields such as agroscience, pharmaceutical, biomedical and biotechnological sectors, and NS research is far from reaching its conclusion. This review gives an overview of CD NS research, focusing on the origin and key points of the historical development in the last 50 years, progressing from relatively simple crosslinked networks in the 1960s to today's multifunctional polymers. The approach adopted in writing the present study consisted in exploring the historical evolution of NSs in order to understand their role today, and imagine their future.

Indexed as

crosslinked polymercyclodextrin nanospongehistory

Identifiers

PMID32423091
PMCPMC7285114
OpenAlexW3024201734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.